Anne Cauvet
Overview
Explore the profile of Anne Cauvet including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
311
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lesturgie-Talarek M, Gonzalez V, Combier A, Thomas M, Boisson M, Poiroux L, et al.
Sci Rep
. 2025 Feb;
15(1):7159.
PMID: 40021771
The objective was to pinpoint specific circulating angiogenic and inflammatory markers of refractory and active RA. We used Luminex technology to measure the concentrations of 17 RA-representative serum angiogenic and...
2.
Hecquet S, Thomas M, Parisel E, Combier A, Wipff J, Cauvet A, et al.
Joint Bone Spine
. 2024 Nov;
92(2):105817.
PMID: 39549973
No abstract available.
3.
Gerges E, Cauvet A, Schwarz M, Avouac J, Allanore Y
Rheumatology (Oxford)
. 2024 Oct;
PMID: 39388243
Objective: To determine serum type I interferon IFN-α2a concentrations in systemic sclerosis (SSc) patients, explore its association with cytokine/chemokine expressions, and evaluate correlation with the phenotype including the predictive value...
4.
Cauvet A, Decellas A, Guignabert C, Rongvaux-Gaida D, Thuillet R, Ottaviani M, et al.
Arthritis Res Ther
. 2023 Sep;
25(1):167.
PMID: 37700377
Background: Uncontrolled T-cell activation plays a key role in systemic sclerosis (SSc). Arsenic trioxide (ATO) has immunological effects and has demonstrated potential in preclinical SSc models. In this study, we...
5.
Avouac J, Vandebeuque E, Combier A, Poiroux L, Steelandt A, Boisson M, et al.
Sci Rep
. 2023 Sep;
13(1):14626.
PMID: 37669994
The lack of validated tools to predict rheumatoid arthritis (RA) disease course warrants the development of new reliable biomarkers. Our aim was to evaluate the merit of circulating SEMA4A for...
6.
Avouac J, Cauvet A, Orvain C, Boulch M, Tilotta F, Tu L, et al.
Arthritis Rheumatol
. 2023 Aug;
76(2):268-278.
PMID: 37610259
Objective: Our goal was to study the tolerance and efficacy of two B cell depletion strategies, including one with CD19-targeted chimeric antigen receptor (CAR) T cells, in a preclinical model...
7.
Frantz C, Cauvet A, Durand A, Gonzalez V, Pierre R, Do Cruzeiro M, et al.
Arthritis Rheumatol
. 2022 Mar;
74(8):1387-1398.
PMID: 35255201
Objective: Systemic sclerosis (SSc) is a debilitating autoimmune disease characterized by severe lung outcomes resulting in reduced life expectancy. Fra-2-transgenic mice offer the opportunity to decipher the relationships between the...
8.
Riccardi A, Martinroche G, Contin-Bordes C, Avouac J, Gobeaux C, Cauvet A, et al.
Semin Arthritis Rheum
. 2022 Jan;
52:151947.
PMID: 35000789
Objective: We aimed to evaluate in two large SSc French cohorts the prevalence and associated factors with the autoantibodies linked to erosive arthritis. Methods: 448 SSc patients were recruited from...
9.
Orvain C, Cauvet A, Prudent A, Guignabert C, Thuillet R, Ottaviani M, et al.
Arthritis Res Ther
. 2022 Jan;
24(1):13.
PMID: 34986869
Background: Uncontrolled immune response with T cell activation has a key role in the pathogenesis of systemic sclerosis (SSc), a disorder that is characterized by generalized fibrosis affecting particularly the...
10.
Kavian N, Mehlal S, Jeljeli M, Saidu N, Nicco C, Cerles O, et al.
Front Immunol
. 2021 Aug;
12:737303.
PMID: 34386019
[This corrects the article DOI: 10.3389/fimmu.2018.01896.].